Skip to main content
logo
Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
90.80
+0.42 (0.46%)
At close: Aug 14, 2026, 4:00 PM EDT
90.51
-0.29 (-0.32%)
Pre-market: Aug 17, 2026, 8:46 AM EDT

Haemonetics Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Revenue
1,3521,3341,3611,3091,169993.2
Revenue Growth
0.44%-1.97%3.96%12.01%17.67%14.10%
Gross Profit
802.16792.87778.55708.57622.87530.77
Operating Income
254.82251.53247.1205.49167.2105.17
Net Income
96.2997.31167.68117.56115.443.38
Earnings Per Share
2.062.053.312.292.240.84
EPS Growth
-37.17%-38.07%44.54%2.23%166.67%-45.81%

Revenue by Segment
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Plasma
-524.46535.43569.54500.49351.95
Blood Center
-221.27261.12283.23289.37294.54
Hospital
-588.3564.27456.29378.21321.58
Revenue (Total)
1,3521,3341,3611,3091,169993.2

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Cash & Investments
224.52246.26308.07180.47285.58259.5
Total Debt
1,1741,2751,283873.88830.76838.3
Net Cash (Debt)
-949.64-1,028-975.28-693.41-545.18-578.81
Net Cash Growth
------
Net Cash Per Share
-20.34-21.72-19.22-13.49-10.60-11.27

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Operating Cash Flow
328.15293.22181.73181.75273.06172.26
Capital Expenditures
-36.93-32.78-39.28-38.13-191.33-96.51
Free Cash Flow
291.22260.44142.45143.6381.7375.75
Free Cash Flow Growth
53.95%82.83%-0.82%75.73%7.89%5.56%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
Gross Margin
59.33%59.43%57.21%54.13%53.30%53.44%
Operating Margin
18.85%18.86%18.16%15.70%14.31%10.59%
Pretax Margin
9.65%9.60%15.58%11.60%12.10%6.41%
Profit Margin
7.12%7.29%12.32%8.98%9.88%4.37%
FCF Margin
21.54%19.52%10.47%10.97%6.99%7.63%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Apr '23 Apr '22
PE Ratio
44.1025.8118.9336.8736.1775.24
Forward PE
16.7710.4613.2120.4925.4523.82
P/FCF Ratio
14.199.6422.2930.1851.0843.08
PS Ratio
3.061.882.333.313.573.29